Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy.

MLA

Alcalá, Sonia, et al. “Targeting Cancer Stem Cell OXPHOS with Tailored Ruthenium Complexes as a New Anti-Cancer Strategy.” Journal of Experimental & Clinical Cancer Research (17569966), vol. 43, no. 1, Jan. 2024, pp. 1–27. EBSCOhost, https://doi.org/10.1186/s13046-023-02931-7.

APA

Alcalá, S., Villarino, L., Ruiz-Cañas, L., Couceiro, J. R., Martínez-Calvo, M., Palencia-Campos, A., Navarro, D., Cabezas-Sainz, P., Rodriguez-Arabaolaza, I., Cordero-Barreal, A., Trilla-Fuertes, L., Rubiolo, J. A., Batres-Ramos, S., Vallespinos, M., González-Páramos, C., Rodríguez, J., Gámez-Pozo, A., Vara, J. Á. F., Fernández, S. F., & Berlinches, A. B. (2024). Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy. Journal of Experimental & Clinical Cancer Research (17569966), 43(1), 1–27. https://doi.org/10.1186/s13046-023-02931-7

Chicago

Alcalá, Sonia, Lara Villarino, Laura Ruiz-Cañas, José R. Couceiro, Miguel Martínez-Calvo, Adrián Palencia-Campos, Diego Navarro, et al. 2024. “Targeting Cancer Stem Cell OXPHOS with Tailored Ruthenium Complexes as a New Anti-Cancer Strategy.” Journal of Experimental & Clinical Cancer Research (17569966) 43 (1): 1–27. doi:10.1186/s13046-023-02931-7.